Patents by Inventor Reuben Saunders

Reuben Saunders has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SARS-COV2 NEUTRALIZING SINGLE DOMAIN ANTIBODY CONSTRUCTS
    Publication number: 20230227538
    Abstract: Antibodies, including single-domain antibodies, that bind to SARS-CoV2 virus and methods of treatment using single-do-main antibodies that bind to SARS-CoV2 virus are provided.
    Type: Application
    Filed: May 12, 2021
    Publication date: July 20, 2023
    Inventors: Peter Walter, Aashish Manglik, Michael SCHOOF, Bryan FAUST, Nicholas HOPPE, Reuben SAUNDERS, Christian BILLESBOELLE
  • CONTROL OF MAMMALIAN GENE DOSAGE USING CRISPR
    Publication number: 20220259593
    Abstract: The present disclosure provides methods and compositions for precisely controlling the expression levels of mammalian genes using CRISPRi or CRISPRa and one or more modified sgRNAs. The methods and compositions are useful for, inter alia, titrating the expression of a gene of interest, identifying drug targets and mechanisms of drug resistance, and enabling the analysis of and control over metabolic and signaling pathway fluxes.
    Type: Application
    Filed: January 25, 2022
    Publication date: August 18, 2022
    Applicant: The Regents of the University of California
    Inventors: Jonathan Weissman, Marco Jost, Maximilian A. Horlbeck, Daniel Santos, Reuben Saunders